| Primary |
| Constipation |
38.5% |
| Foreign Body |
15.4% |
| Hepatic Cirrhosis |
15.4% |
| Hepatic Encephalopathy |
15.4% |
| Liver Disorder |
7.7% |
| Product Used For Unknown Indication |
7.7% |
|
| Gastrointestinal Haemorrhage |
14.3% |
| Faecaloma |
9.5% |
| Ammonia Increased |
4.8% |
| Bronchospasm |
4.8% |
| Insomnia |
4.8% |
| Jaundice |
4.8% |
| Lower Gastrointestinal Haemorrhage |
4.8% |
| Pharmaceutical Product Complaint |
4.8% |
| Pneumonia Aspiration |
4.8% |
| Presyncope |
4.8% |
| Product Substitution Issue |
4.8% |
| Rectal Ulcer |
4.8% |
| Renal Failure |
4.8% |
| Syncope |
4.8% |
| Therapeutic Response Unexpected With Drug Substitution |
4.8% |
| Thrombosis |
4.8% |
| Tremor |
4.8% |
| Weight Decreased |
4.8% |
|
| Secondary |
| Schizophrenia |
40.0% |
| Urinary Tract Infection |
26.7% |
| Constipation |
20.0% |
| Foreign Body |
13.3% |
|
| Jaundice Cholestatic |
25.0% |
| Drug Ineffective |
12.5% |
| Oesophagitis |
12.5% |
| Pneumonia Aspiration |
12.5% |
| Rash Generalised |
12.5% |
| Skin Disorder |
12.5% |
| White Blood Cell Count Increased |
12.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.8% |
| Drug Use For Unknown Indication |
26.1% |
| Pain |
5.1% |
| Hypertension |
4.3% |
| Nausea |
3.8% |
| Non-small Cell Lung Cancer |
3.4% |
| Metastases To Bone |
3.3% |
| Acute Lymphocytic Leukaemia |
2.6% |
| Constipation |
2.4% |
| Prophylaxis |
2.1% |
| Anxiety |
2.0% |
| Depression |
2.0% |
| Peripheral Sensory Neuropathy |
1.8% |
| Pancreatic Carcinoma |
1.5% |
| Plasma Cell Myeloma |
1.5% |
| Back Pain |
1.3% |
| Parkinson's Disease |
1.3% |
| Prostate Cancer |
1.3% |
| Vitamin Supplementation |
1.3% |
| Breast Cancer |
1.2% |
|
| Weight Decreased |
20.4% |
| Unresponsive To Stimuli |
10.2% |
| Vomiting |
8.2% |
| Visual Impairment |
6.1% |
| Hepatic Cirrhosis |
5.1% |
| Hepatic Encephalopathy |
5.1% |
| Pneumonia |
4.1% |
| Productive Cough |
4.1% |
| Tardive Dyskinesia |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Diarrhoea |
3.1% |
| Dyspnoea |
3.1% |
| Lung Neoplasm Malignant |
3.1% |
| Pancreatic Carcinoma Metastatic |
3.1% |
| Renal Failure |
3.1% |
| Sepsis |
3.1% |
| Thrombocytopenia |
3.1% |
| Urinary Tract Infection |
3.1% |
| Back Pain |
2.0% |
| Dizziness |
2.0% |
|
